CompoAtlas

Internal Flush

Internal Flush, licence 80023850: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

Natural health product licensed in Canada

Other names
I.F. Formula, Internal Flush For Men
Licence holder
1338299 Ontario Ltd o/a Integrity Marketing
NPN or DIN-HM
80023850
Status
Active licence
Licence date
18 February 2011
Revision date
23 August 2012
Form
Capsule
Route of administration
Orale
Application type
Non traditionnelle

If this product were sold in France

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Ulmus rubra

Source : Stem bark - inner

20.0 mgNot calculated
Plantago ovata

Source : Enveloppe

200.0 mgNot calculated
Rubus idaeus

Source : Feuille

20.0 mgNot calculated
Zingiber officinale

Source : Rhizome

20.0 mgNot calculated
Foeniculum vulgare subsp. vulgare var. vulgare

Source : Graine(s)

20.0 mgNot calculated
Rheum officinale

Source : Racine

Extraction ratio : 4:1

Dry plant equivalent : 100 mg

25.0 mgNot calculated
Althaea officinalis

Source : Racine

20.0 mgNot calculated
Hydrastis canadensis

Source : Racine

50.0 mgNot calculated
Hydrastis canadensis

Source : Rhizome

50.0 mgNot calculated

Non-medicinal ingredients

Gélatine, Stéarate de magnésium

PopulationAgeQuantity per servingFrequency
AdultesNot specifiedminimum: 3.0 Capsule ; maximum: 6.0 Capsule1.0 Tous les jours

Uses authorised in Canada

Text supplied in English because no French text is available.

For the short-term relief of occasional constipation. Promotes bowel movement (by direct action on the large intestine). Stimulant laxative.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Source

Official Health Canada record, licence 80023850

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).

List recorded in 2012. Photograph the packaging to check whether it has changed.

Has the product changed? Photograph the packaging.

List recorded in 2012. Photograph the packaging to check whether it has changed.

Enter to analyse, Shift+Enter for a new line